phenytoin has been researched along with Cranial Nerve II Injuries in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenytoin is a well-characterized sodium channel blocker in widespread use as an anticonvulsant." | 1.31 | Phenytoin blocks retinal ganglion cell death after partial optic nerve crush. ( Naskar, R; Quinto, K; Romann, I; Schuettauf, F; Zurakowski, D, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naskar, R | 1 |
| Quinto, K | 1 |
| Romann, I | 1 |
| Schuettauf, F | 1 |
| Zurakowski, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Cohort Study of Association Between Steady State Phenytoin Treatment and Better Clinical Parameters of Glaucoma[NCT00739154] | 200 participants (Anticipated) | Observational | 2008-11-30 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for phenytoin and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Phenytoin blocks retinal ganglion cell death after partial optic nerve crush.
Topics: Analysis of Variance; Animals; Calcium; Cell Death; Cell Survival; Drug Therapy, Combination; Excita | 2002 |